Patient blood management market seen reaching $22.98 billion by 2030

The Business Research Company says the patient blood management market is set to grow from $15.95 billion in 2026 to $22.98 billion by 2030, driven by more surgeries, aging populations and tighter transfusion rules. North America held the largest share in 2025, while PBM adoption is expanding across hospitals and emerging markets.

Why it matters: - Patient blood management is becoming more important as hospitals look to reduce transfusion risks, improve surgical outcomes and use blood more efficiently. - The expected jump to $22.98 billion by 2030 signals a shift from slow historical growth to a faster expansion phase for PBM tools and programs. - Higher surgical volumes and aging populations are increasing demand for blood-sparing care.

What happened: - The Business Research Company released a patient blood management market outlook on Aug. 21, 2026. - The report estimates the market will rise from $15.94 billion in 2025 to $15.95 billion in 2026. - The same report projects the market will reach $22.98 billion by 2030. - The forecast implies a 9.6% CAGR from 2026 to 2030. - North America held the largest regional share in 2025. - Western Europe ranked second among regional markets.

The details: - Patient blood management is an evidence-based, patient-centered approach to optimize care for people who may need transfusions. - PBM focuses on improving patients' own blood health, reducing blood loss during surgery and limiting reliance on allogeneic blood transfusions. - The report ties historical growth to surgical volume increases, blood supply shortages, transfusion concerns, hospital cost pressure and more standardized clinical guidelines. - The report points to an expanding elderly population, more elective surgeries, stricter transfusion rules, wider use of value-based care and adoption in emerging economies as main growth drivers through 2030. - The report highlights preoperative anemia screening, point-of-care hemoglobin testing, standardized transfusion guidelines, multidisciplinary hospital PBM programs and clinician education as key trends. - The report says growing surgical interventions are a primary catalyst for PBM demand. - In August 2023, The Aesthetic Society reported Americans spent over $11.8 billion on aesthetic procedures, up 2% from 2022. - The report covers additional regions including Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available at the report sample. - The full report is available at the full market report.

Between the lines: - The near-flat 2025-to-2026 growth suggests the market is still early in its adoption curve. - The stronger 2030 forecast suggests PBM is moving from a niche clinical practice to a broader operational priority for hospitals. - Faster uptake in emerging economies could matter because PBM adoption there can expand the market beyond mature healthcare systems.

What's next: - Hospitals are likely to expand anemia screening, hemoglobin testing and transfusion protocols as PBM becomes more embedded in routine care. - Training and multidisciplinary PBM programs may become more common as clinicians adopt standardized workflows. - Market growth will likely track surgical demand, regulatory pressure and the pace of PBM adoption in new regions. - The Business Research Company says its latest 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards and trend graphics.

The bottom line: - Patient blood management is poised for a faster growth phase through 2030 as healthcare systems try to improve outcomes while reducing transfusion dependence.